Er‐Bin Zhang

632 total citations
8 papers, 282 citations indexed

About

Er‐Bin Zhang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Er‐Bin Zhang has authored 8 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Er‐Bin Zhang's work include Cancer, Hypoxia, and Metabolism (2 papers), RNA modifications and cancer (1 paper) and Click Chemistry and Applications (1 paper). Er‐Bin Zhang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), RNA modifications and cancer (1 paper) and Click Chemistry and Applications (1 paper). Er‐Bin Zhang collaborates with scholars based in China, United States and Singapore. Er‐Bin Zhang's co-authors include Dong Xie, Ning Ma, Jing‐Jing Li, Yanmei Yuan, Tianwei Chen, Shuqun Cheng, Cheng‐Qian Zhong, Yabo Jiang, Lin Qiu and Dongxian Guan and has published in prestigious journals such as Nature Communications, Hepatology and Oncogene.

In The Last Decade

Er‐Bin Zhang

8 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Er‐Bin Zhang China 8 188 114 53 40 32 8 282
Atsutaka Masuda Japan 9 142 0.8× 92 0.8× 85 1.6× 61 1.5× 51 1.6× 19 279
Letizia Satriano Denmark 5 132 0.7× 104 0.9× 55 1.0× 34 0.8× 36 1.1× 6 250
Mujian Teng China 10 227 1.2× 164 1.4× 62 1.2× 22 0.6× 21 0.7× 11 335
Shuya Bai China 10 178 0.9× 108 0.9× 137 2.6× 39 1.0× 34 1.1× 22 312
Mingwen Huang China 10 142 0.8× 74 0.6× 87 1.6× 40 1.0× 54 1.7× 22 279
Linghua Zhu China 9 130 0.7× 83 0.7× 34 0.6× 43 1.1× 57 1.8× 26 263
Linling Ju China 11 208 1.1× 113 1.0× 45 0.8× 22 0.6× 69 2.2× 41 314
Zheng Dang China 8 263 1.4× 190 1.7× 84 1.6× 27 0.7× 20 0.6× 9 343
Yajuan Cao China 5 216 1.1× 189 1.7× 53 1.0× 33 0.8× 52 1.6× 16 308
Samar Masoumi Moghaddam Australia 5 185 1.0× 68 0.6× 102 1.9× 24 0.6× 31 1.0× 6 323

Countries citing papers authored by Er‐Bin Zhang

Since Specialization
Citations

This map shows the geographic impact of Er‐Bin Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Er‐Bin Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Er‐Bin Zhang more than expected).

Fields of papers citing papers by Er‐Bin Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Er‐Bin Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Er‐Bin Zhang. The network helps show where Er‐Bin Zhang may publish in the future.

Co-authorship network of co-authors of Er‐Bin Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Er‐Bin Zhang. A scholar is included among the top collaborators of Er‐Bin Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Er‐Bin Zhang. Er‐Bin Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Zheng, Qian‐Wen, Qian‐Zhi Ni, Bing Zhu, et al.. (2022). PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3. Oncogene. 41(36). 4244–4256. 10 indexed citations
2.
Zhang, Er‐Bin, Xiuping Zhang, Kang Wang, et al.. (2021). Antifungal agent Terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axis. Oncogene. 40(34). 5302–5313. 21 indexed citations
3.
Yuan, Yanmei, Ning Ma, Er‐Bin Zhang, et al.. (2019). BMP10 suppresses hepatocellular carcinoma progression via PTPRS–STAT3 axis. Oncogene. 38(48). 7281–7293. 14 indexed citations
4.
Chen, Tianwei, Yanmei Yuan, Dongxian Guan, et al.. (2019). CHML promotes liver cancer metastasis by facilitating Rab14 recycle. Nature Communications. 10(1). 2510–2510. 33 indexed citations
5.
Zhang, Xiuping, Yabo Jiang, Cheng‐Qian Zhong, et al.. (2018). PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway. Cellular Physiology and Biochemistry. 47(4). 1643–1654. 35 indexed citations
6.
Zhong, Cheng‐Qian, Ning Ma, Er‐Bin Zhang, et al.. (2018). FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma. Cancer Medicine. 7(6). 2629–2640. 65 indexed citations
7.
Jiang, Hao, Ning Ma, Wentao Zhou, et al.. (2016). Triosephosphate isomerase 1 suppresses growth, migration and invasion of hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications. 482(4). 1048–1053. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026